Supporting this observation, TGFB2–Smad3 pathway has been demonstrated to promote proliferation and epithelial–mesenchymal transition in several cancers, recently also in bladder cancer [14, 15]. This evidence concerns the gene SMAD3 and urinary bladder carcinoma.